Developing a technology platform called Parallel Quantitative Biology (PQB) enabling the field of Systems Biology – systems level understanding of the functional pathways of the cell, including roles and modulations of these pathways in drug response and disease. Panomics was acquired by Affymetrix (NASDAQ:AFFX).
Panomics
